Skip to main content
. Author manuscript; available in PMC: 2016 May 9.
Published in final edited form as: Vaccine. 2011 Sep 3;29(46):8302–8308. doi: 10.1016/j.vaccine.2011.08.093

Table 3.

Neurological diagnoses in 212 H1N1 case reports reviewed by CISA

Diagnosis No. of case reports in this group (n = 212) % of total case reports reviewed
Guillain-Barré Syndrome (GBS)
75 met Brighton Collaborationa diagnostic criteria, 4 did not but were physician diagnosed.
79 37.3
Seizure 23 10.8
Cranial Neuropathy 12 5.7
Demyelinating disorder of unclear etiology 9 4.2
Acute Demyelinating Encephalomyelitis (ADEM) 8 3.8
Weakness of unclear etiology 8 3.8
Cerebrovascular Disease 7 3.3
Encephalitis 7 3.3
Parasthesias 7 3.3
Psychogenic 7 3.3
Demyelinating disorder of known etiology 7 3.3
Sensory Neuropathy 5 2.4
Meningitis 4 1.9
Movement Disorder 3 1.4
Syncope 2 0.9
Miscellaneousb 24 11.3
a

Brighton Collaboration[10]

b

Acute Vestibular Neuritis, Acute Vestibular Neuritis, Memory loss, Migraine, Speech impairment, Hearing loss, Hypertensive encephalopathy, Brachial plexopathy, Possible Corticobasilar Degeneration Syndrome, Myastenia Gravis exacerbation, Pain syndrome, Diabetic Radiculopathy, Degenerative Disc Disease of the Spine, Dystonia, Cerebellitis, Diffuse body numbness/pain, Brain tumor, Myalgias, Nonspecific disease, Transverse Myelitis vs Neoplasm, Spinal stenosis, Fluctuating neurological symptoms, , ADEM vs transverse myelitis vs tumor, Idiopathic Thrombocytopenic Purpura